Related Experiment Video
Updated: Aug 7, 2026
09:26
In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
HIV-related diarrhea and outcome measures
1School of Nursing, Columbia University, USA.
The Journal of the Association of Nurses in AIDS Care : JANAC
|September 21, 2001
Summary
This study identifies key causes of diarrhea in individuals with HIV/AIDS. It also evaluates various stool outcome measures for gastrointestinal research, discussing their pros and cons.
Area of Science:
- Gastroenterology
- Infectious Diseases
- HIV/AIDS Research
Background:
- Diarrhea is a common and serious complication in individuals with Human Immunodeficiency Virus (HIV).
- Accurate assessment of fecal outcomes is crucial for evaluating treatments and understanding disease progression in gastrointestinal studies.
Purpose of the Study:
- To identify the primary causes of diarrhea in the context of HIV infection.
- To review and critically evaluate existing stool outcome measures used in gastrointestinal research.
- To discuss the advantages and limitations of various quantitative instruments for assessing stool outcomes.
Main Methods:
- Literature review and synthesis of primary causes of HIV-related diarrhea.
- Systematic evaluation of stool outcome measures, including instruments and scales.
- Comparative analysis of the strengths and weaknesses of different assessment tools.
Main Results:
- Key etiological factors contributing to HIV-associated diarrhea have been identified.
- A range of stool outcome measures were assessed for their utility and limitations.
- Specific instruments and scales demonstrate varying degrees of effectiveness and applicability.
Conclusions:
- Understanding the causes of HIV-related diarrhea is essential for effective management.
- The selection of appropriate stool outcome measures is critical for robust gastrointestinal research in HIV.
- Further refinement and validation of assessment tools may be necessary to improve the evaluation of fecal outcomes.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...